KORU Medical Systems (NASDAQ:KRMD) Rating Increased to Strong-Buy at B. Riley

B. Riley upgraded shares of KORU Medical Systems (NASDAQ:KRMD) to a strong-buy rating in a research note issued to investors on Wednesday morning, Zacks.com reports.

KORU Medical Systems Stock Performance

NASDAQ:KRMD opened at $2.47 on Wednesday. The stock’s 50-day moving average is $2.41 and its 200-day moving average is $2.26. KORU Medical Systems has a 1-year low of $1.98 and a 1-year high of $3.12. The company has a current ratio of 4.01, a quick ratio of 3.37 and a debt-to-equity ratio of 0.02. The stock has a market cap of $113.03 million, a P/E ratio of -8.82 and a beta of 0.40.

KORU Medical Systems (NASDAQ:KRMD) last posted its earnings results on Wednesday, May 1st. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. The firm had revenue of $8.20 million for the quarter, compared to analyst estimates of $7.49 million. KORU Medical Systems had a negative net margin of 45.24% and a negative return on equity of 25.10%. During the same period in the previous year, the firm posted ($0.05) EPS. Equities research analysts anticipate that KORU Medical Systems will post -0.15 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Legato Capital Management LLC acquired a new stake in shares of KORU Medical Systems in the second quarter valued at about $35,000. Allspring Global Investments Holdings LLC acquired a new position in shares of KORU Medical Systems in the second quarter worth approximately $28,000. Aaron Wealth Advisors LLC bought a new stake in KORU Medical Systems in the second quarter valued at approximately $28,000. Lakewood Asset Management LLC increased its position in KORU Medical Systems by 13.9% during the 2nd quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock valued at $181,000 after purchasing an additional 8,300 shares during the period. Finally, Virtu Financial LLC bought a new position in KORU Medical Systems during the 1st quarter worth approximately $63,000. 58.60% of the stock is owned by institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.